Animal Vaccines Market Insights:
Animal Vaccines Market was valued at USD 10.5 Billion in 2021, registering a CAGR of 5.7% during the forecast period (2022-2030), the market is projected to be worth USD 17.3 Billion by 2030. The major aim of animal vaccines is to prevent the transmission of diseases among animals. As animals serve an essential role of providing sources such as milk, meat, food, protein, and others, there is a constant need of animal vaccines development due to the increased emergence of animal diseases. Thus, veterinary vaccines such as rabies vaccine, equine influenza virus vaccines, and foot & mouth diseases vaccines are essential for contributing to the growth of animal vaccines market in the forecast period.
The leading companies in this field allot high budgets for research and development of animal vaccines. For instance, in May 2021, an American firm named Zoetis introduced a sustainability initiative called “Driven to Care” which aims to develop vaccines for emerging diseases such as African swine fever, foot, and mouth disease, and SARS-CoV-2. Furthermore, the unprecedented rise in the urban population is expected to have a significant impact on demand for livestock products due to the availability of improved infrastructure such as cold chain for easier transportation of perishable meat goods, particularly in Africa and Asia. For instance, the West African Meat and Livestock Chain operators have launched the project to facilitate the hygienic transportation and marketing of meat to promote safety and environmental regulations. Based on region, North America is estimated to contribute the largest share to the growth of the animal vaccines market. The factors such as a rise in animal adoption rates, high consumption of meat and milk, and increased awareness of animal vaccines are also expected to support the growth of the animal vaccines market.
Animal Vaccines Market Dynamics:
An animal vaccine is administered to animals for protection against antibiotic-resistant bacteria and the prevention of contagious diseases among animals. This results in a stronger immune response to infectious diseases such as Newcastle disease (ND), classical swine fever (CSF), Lumpy skin disease (LSD), and others.
Driver:
The rise of human dependency for getting sources such as meat, milk, and proteins from animals is expected to drive the growth of the animal vaccines market. Also, factors such as higher food security concerns, increased animal husbandry, and the increased awareness of animal vaccination are anticipated to drive the market growth during the forecast period.
Restraint:
The lack of veterinary health awareness, expensive costs of vaccines combined with insufficient availability of vaccines in developing countries such as Africa and India hamper the growth of the animal vaccines market. Also, the factors such as unprecedented veterinary vaccine failures, shortage of skilled professionals in the field, high costs for vaccine storage, and limited infrastructural facilities are challenges to the growth of the animal vaccines market.
Opportunity:
The surge in research and development studies for veterinary vaccine development increased government support and the boost in animal vaccine demand is anticipated to create profitable opportunities for the growth of the animal vaccines market.
COVID-19 Analysis of Animal Vaccines Market:
The animal vaccines market has been significantly impacted due to the COVID-19 pandemic in many different parts of the world. The factors such as poor supply chain, fall in the number of veterinary visits, limited availability of vaccines, and economic slowdown are the major impacts of COVID-19 on hampered the growth of the animal vaccines market. In the initial phases of the pandemic, the speculation of COVID-19 transmission through birds harmed the livestock industry. In the U.S., the poultry processing plants were shut down during the major outbreak. However, the nation’s circumstances have stabilized. As a result, it is determined that COVID-19’s overall impact on the animal vaccines market is moderate. Post covid-19 there was a positive impact on the animal vaccines market as consumers were more focused on safeguarding animal health through vaccination.
Animal Vaccines Market Report Coverage:
| Report Attributes | Report Details |
| Study Timeline | 2016-2030 |
| Market Size in 2030 (USD Billion) | 17.3 Billion |
| CAGR (2022-2030) | 5.7% |
| By Product | Inactivated, Live Attenuated, Subunit Vaccines, Recombinant, DNA Vaccines, And Others |
| By Animal Type | Companion Animal (Cats and Dogs), Livestock Animal (Pigs, Sheep, Cattle, Poultry, Goats, Camels, And Others), and Aquaculture |
| By Route Of Administration | Subcutaneous, Intramuscular, Intranasal |
| By Distribution Channel | Veterinary Hospitals, Veterinary clinics, Pharmacies, drug stores, and Others |
| By Geography | North America– (U.S., Canada, Mexico
Europe- (Germany, France, U.K., Russia, Italy, Spain, BENELUX, Rest of Europe) Asia Pacific- (China, Japan, India, South Korea, Australia, ASEAN, Rest of Asia Pacific) Latin America- (Brazil, Argentina, Chile, Rest of Latin America) Middle East and Africa- (GCC, Turkey, Israel, Rest of MEA) |
| Key Players | Zoetis, Virbac SA, Merck, Phibro Animal Health Corporation, Boehringer Ingelheim, Ceva, Pfizer, Elanco, Hygieia Biological Laboratories, Arko Laboratories, Ltd |
Animal Vaccines Market Segment Analysis:
By Product
The product segment is divided into inactivated, live attenuated, subunit vaccines, recombinant, DNA vaccines, and others. In 2021, the live attenuated segment contributed the largest revenue share of 35.2% to the growth of the animal vaccines market due to the strong triggering of immunity response as compared to other vaccines. Live attenuation is one of the oldest vaccination methods which also has the potential to provide additional applications. These live attenuated vaccines introduce live pathogens into the body to stimulate the immune response by mimicking the pathogen pattern. Furthermore, the subunit vaccines segment is also anticipated to witness substantial growth over the forecast period due to the reduced needs of booster vaccinations, fewer side-effects at injection sites, safer vaccine ingredients such as protein or polysaccharides, and high immune response. Thus, the subunit vaccines segment is also expected to support the animal vaccines market growth in the forecast period.
By Animal Type
The animal type is segmented into companion animal, livestock animal, and aquaculture. The livestock segment contributed the largest market revenue of over 70.5% in 2021 owing to the increased milk, meat, and dairy products consumption. The livestock segment is further divided into pigs, sheep, cattle, poultry, goats, camels, and others. Additionally, the factors such as the growing numbers of livestock population, and increased outbreak incidences among cattle and sheep combined with relevant government initiatives for vaccine development support the growth of the livestock segment. Furthermore, the companion segment is also anticipated to exhibit the fastest growth during the forecast period. The companion segment is further classified into cats and dogs. The rising incidences of canine distemper virus among house pets require stricter vaccination measures due to the high rate of infection transmission through the air and direct contact. Thus, the immunization of dogs is essential to prevent the gastrointestinal tract infection caused by the canine distemper virus as newborn puppies are most vulnerable to this disease. The vaccines like DHPPi/L vaccine, Vanguard, and Megavac 6 and 7 aid in the prevention of canine distemper which supports the growth of the animal vaccines market.
By Route of Administration
Based on the route of administration, the segment is divided into subcutaneous, intramuscular, and intranasal. In 2021, the subcutaneous segment is anticipated to contribute the largest revenue share of 40.2% due to the benefits such as the ease of vaccine administration and quick absorption of the drug into the body. The region behind the shoulder blades and neck of animals is known as the subcutaneous injection site. The easy administration of injections in these subcutaneous regions is less painful for animals. Thus, veterinary doctors require minimum training to administer subcutaneous injections. Additionally, the intranasal vaccines are limited to a single dose which is easily administered to animals due to their natural sense of sniffing. Thus, the growing rates of respiratory diseases among animals and the need for enhanced vaccines are expected to fuel the growth of the animal vaccines market.
By Distribution Channel
The distribution channel segment is categorized into veterinary hospitals, pharmacies, drug stores, veterinary clinics, and others. The veterinary hospitals’ segment held the leading share in the animal vaccines market. The growing numbers of zoonotic diseases such as bird flu, E.coli infection, and monkeypox among animals and increased expenditure on pet treatment are driving the growth of the veterinary hospital segment. Veterinary hospitals have skilled professionals in the field and advanced medical facilities for the treatment of such highly contagious diseases. Additionally, the factors such as favorable reimbursement policies, ease of access to medical facilities, and low-cost treatments are expected to augment the growth of the veterinary clinics’ segment during the projected period. Hence, the above-mentioned segments are expected to boost the growth of the animal vaccines market in the forecast period.
By Region
The regional segment includes Asia Pacific, Europe, North America, Middle East, and Africa, Latin America. In 2021, North America accounted for the largest market share of 25.5% to the increased market growth. North America has a high prevalence of livestock combined with increased mortality rates due to zoonotic diseases. Also, the rise in the number of pet owners and the large presence of leading pharmaceutical firms that focus on high expenditures on vaccine development is anticipated to support the growth of the animal vaccines market in North America.
In the Asia Pacific, the animal vaccines market is projected to register the fastest growth rate during the forecast period. The factors such as the high market potential for animal-based food products, the rise in the research and development of innovative vaccine development technology, and the rise in the number of pet owners are expected to fuel the growth of the animal vaccines market in the Asia Pacific region.
Animal Vaccines Market Competitive Landscape:
The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Further, the surge in Research and Development (R&D), product innovation, various business strategies, and Application launches have accelerated the growth of the Sample Preparation market. Key players in the market include-
- Zoetis
- Virbac SA
- Merk
- Elanco
- Phibro Animal Health Corporation
- Boehringer Ingelheim
- Ceva
- Pfizer
- Hygieia Biological Laboratories
- Arko Laboratories, Ltd
Table of Content
- Introduction
- Market Introduction
- Market Research Methodology
- Research Process
- Primary Research
- Secondary Research
- Data Collection Technique
- Data Sources
- Market Estimation Methodology
- Limitations of the Study
- Product Picture of Animal vaccines
- Global Animal Vaccines Market: Classification
- Geographic Scope
- Years Considered for the Study
- Research Methodology in brief
- Parent Market Overview
- Overall Animal Vaccines Market Regional Demand
- Research Programs/Design
- Market Breakdown and Data Triangulation Approach
- Data Source
- Secondary Sources
- Primary Sources
- Primary Interviews
- Average primary breakdown ratio
- Market Dynamics
- Drivers
- Drivers
- Restraints
- Restraints
- Opportunity
- Impact forces on market dynamics
- Impact forces during the forecast years
- Industry Value Chain
- Upstream analysis
- Downstream analysis
- Distribution Channel
- Direct Channel
- Indirect Channel
- Potential Customers
- Manufacturing/Operational Cost Analysis
- Pricing Analysis by Region
- Key Technology Landscape
- Regulatory Analysis
- Porter’s Analysis
- Supplier Power
- Buyer Power
- Substitution Threat
- Threat from New Entry
- Competitive Rivalry
- PESTEL Analysis
- Political Factors
- Economic Factor
- Social Factors
- Technological Factor
- Environmental Factors
- Legal Factor
- Covid-19 impact on Global Economy
- Covid-19 impact on Animal Vaccines demand
- Post-Covid Impact on Animal Vaccines Market Demand
- Impact Analysis of Russia-Ukraine Conflict
- Drivers
- Global Animal Vaccines Market Segmentation, by Revenue (USD Billion), (2022-2030)
- By Product
- Inactivated
- Live Attenuated
- Subunit Vaccines
- Recombinant
- DNA Vaccines
- Others
- By Animal Type
- Companion Animal
- Cats
- Dogs
- Livestock Animal
- Pigs
- Sheep
- Cattle
- Poultry
- Goats
- Camels
- Others
- Aquaculture
- Companion Animal
- By Route of Administration
- Subcutaneous
- Intramuscular
- Intranasal
- By Distribution Channel
- Veterinary Hospitals
- Veterinary clinics
- Pharmacies and drug stores
- Others
- By Product
- Global Animal Vaccines Market Overview, By Region
- North America Animal Vaccines Market Revenue (USD Billion), by Countries, (2022-2030)
- US
- By Product
- By Animal Type
- By Route of Administration
- By Distribution Channel
- Canada
- Mexico
- US
- Europe Animal Vaccines Market Revenue (USD Billion), by Countries, (2022-2030)
- France
- UK
- Spain
- Russia
- Italy
- BENELUX
- Asia Pacific Animal Vaccines Market Revenue (USD Billion), by Countries, (2022-2030)
- China
- Japan
- Australia
- South Korea
- India
- ASEAN
- North America Animal Vaccines Market Revenue (USD Billion), by Countries, (2022-2030)
- Latin America Animal Vaccines Market Revenue (USD Billion), by Countries, (2022-2030)
- Brazil
- Argentina
- Chile
- Middle East and Africa Animal Vaccines Market Revenue (USD Billion), by Countries, (2022-2030)
- GCC
- Turkey
- South Africa
- Global Animal Vaccines Market Revenue: Competitive Analysis, 2021
- Key strategies by players
- Revenue (USD Billion and %), By manufacturers, 2021
- Player Positioning by Market Players, 2021
- Competitive Analysis
- Zoetis
- Business Overview
- Business Financials (USD Billion)
- Product Category, Type, and Specification
- Main Business/Business Overview
- Geographical Analysis
- Recent Development
- Swot Analysis
- Virbac SA
- Merk
- Elanco
- Phibro Animal Health Corporation
- Boehringer Ingelheim
- Ceva
- Pfizer
- Hygieia Biological Laboratories
- Arko Laboratories, Ltd
- Zoetis
- Market Research Findings & Conclusion
Disclaimer
Research Methodology
The Market Research Community offers numerous solutions and its full addition in the research methods to be skilled at each step. We use wide-ranging resources to produce the best outcome for our customers. The achievement of a research development is completely reliant on the research methods implemented by the company. We always faithful to our clients to find opportunities by examining the global market and offering economic insights.Market Research Community are proud of our widespread coverage that encompasses the understanding of numerous major industry domains. Company offers consistency in our research report, we also offers on the part of the analysis of forecast across a range of coverage geographies and coverage. The research teams carry out primary and secondary research to carry out and design the data collection methods.